RecruitingNCT06605378

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

A Cross-Sectional, Observational Study of the Prevalence of Adenoviral-Specific Antibodies and Inflammatory Cytokines in Participants With Chronic Granulomatous Disease

Sponsor

Ensoma

Enrollment

60 participants

Start Date

Nov 18, 2024

Study Type

OBSERVATIONAL

Conditions

Chronic Granulomatous Disease (CGD)

Summary

This research study is designed to assess the prevalence of specific antibodies and inflammatory cytokines in adult and pediatric participants with CGD.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with chronic granulomatous disease (cgd). The study is currently recruiting participants at 52 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(52)

Home-based telemedicine

Montgomery, Alabama, United States

Home-based telemedicine

Phoenix, Arizona, United States

Home-based telemedicine

Little Rock, Arkansas, United States

Home-based telemedicine

Sacramento, California, United States

University of California, San Francisco

San Francisco, California, United States

Home-based telemedicine

Denver, Colorado, United States

Home-based telemedicine

Hartford, Connecticut, United States

Home-based telemedicine

Dover, Delaware, United States

Home-based telemedicine

Washington D.C., District of Columbia, United States

Home-based telemedicine

Tallahassee, Florida, United States

Home-based telemedicine

Atlanta, Georgia, United States

Home-based telemedicine

Boise, Idaho, United States

Home-based telemedicine

Springfield, Illinois, United States

Home-based telemedicine

Indianapolis, Indiana, United States

Home-based telemedicine

Des Moines, Iowa, United States

Home-based telemedicine

Topeka, Kansas, United States

Home-based telemedicine

Frankfort, Kentucky, United States

Home-based telemedicine

Baton Rouge, Louisiana, United States

Home-based telemedicine

Augusta, Maine, United States

Home-based telemedicine

Annapolis, Maryland, United States

Home-based telemedicine

Boston, Massachusetts, United States

Home-based telemedicine

Lansing, Michigan, United States

Home-based telemedicine

Saint Paul, Minnesota, United States

Home-based telemedicine

Jackson, Mississippi, United States

Home-based telemedicine

Jefferson City, Missouri, United States

Home-based telemedicine

Helena, Montana, United States

Home-based telemedicine

Lincoln, Nebraska, United States

Home-based telemedicine

Carson City, Nevada, United States

Home-based telemedicine

Concord, New Hampshire, United States

Home-based telemedicine

Trenton, New Jersey, United States

Home-based telemedicine

Santa Fe, New Mexico, United States

Home-based telemedicine

Albany, New York, United States

Science 37, Inc

Morrisville, North Carolina, United States

Home-based telemedicine

Bismarck, North Dakota, United States

Home-based telemedicine

Columbus, Ohio, United States

Home-based telemedicine

Oklahoma City, Oklahoma, United States

Home-based telemedicine

Salem, Oregon, United States

Home-based telemedicine

Harrisburg, Pennsylvania, United States

Home-based telemedicine

Providence, Rhode Island, United States

Home-based telemedicine

Columbia, South Carolina, United States

Home-based telemedicine

Pierre, South Dakota, United States

Home-based telemedicine

Nashville, Tennessee, United States

Home-based telemedicine

Austin, Texas, United States

Home-based telemedicine

Salt Lake City, Utah, United States

Home-based telemedicine

Montpelier, Vermont, United States

Home-based telemedicine

Richmond, Virginia, United States

Home-based telemedicine

Olympia, Washington, United States

Home-based telemedicine

Charleston, West Virginia, United States

Home-based telemedicine

Madison, Wisconsin, United States

Home-based telemedicine

Cheyenne, Wyoming, United States

Great Ormond Street Hospital for Children

London, United Kingdom

Royal Free London NHS Foundation Trust

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06605378

Related Trials

Open-label Gene Therapy Study in p47-CGD

NCT07826767

Evaluation of Patients With Immune Function Abnormalities

NCT001289731 location

Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease

NCT063257091 location